American Journal of Epidemiology Vol. 125, No. 1: 12-16
Copyright © 1987 by The Johns Hopkins University School of Hygiene and Public Health
research-article |
IS SERUM SELENIUM A RISK FACTOR FOR CANCER IN MEN ONLY?1
2Reprint requests to Dr. Frans J. Kok, Department of Epidemiology, Erasmus UniversityMedical School P.O. Box 1738,3000 DR Rotterdam, The Netherlands.
The association of serum selenium with the subsequent risk of death from cancer was investigated in a case-control study that was nested in a prospective nine-year follow-up study In the Netherlands. In 1975–1978, 10,532 persons in the Dutch town of Zoetermeer who were aged five years or more participated in a medical survey. Serum samples were collected and stored at -20 C. For the 82 persons who died of cancer since the baseline examination, 164 cohort members still alive by the end of 1983 were selected as controls and matched for age, sex, and smoking. Cancer deaths that occurred in the first year of follow-up were excluded, leaving 69 cases for statistical analyses. The mean serum selenium level of 116.7 ± 4.0 ng/iner among male cancer deaths (n = 40) was significantly different (p = 0.04) from that in the control subjects (126.4 ± 3.1 ng/ liter). In females, selenium levels were similar among cases and controls. The adjusted risk of death from cancer for men in the lowest quintile of serum selenium (below 100.8 /tg/liter) was more than twice that of subjects with higher levels (relative risk = 2.7,90% confidence interval = 1.2–6.2). These data support recent findings of an increased cancer risk associated with low serum selenium levels in men but not in women.
longitudinal studies; neoplasms; selenium
Department of Epidemiology, Erasmus University Medical School, Rotterdam, The Netherlands.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Bardia, I. M. Tleyjeh, J. R. Cerhan, A. K. Sood, P. J. Limburg, P. J. Erwin, and V. M. Montori Efficacy of Antioxidant Supplementation in Reducing Primary Cancer Incidence and Mortality: Systematic Review and Meta-analysis Mayo Clin. Proc., January 1, 2008; 83(1): 23 - 34. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Hercberg, K. Ezzedine, C. Guinot, P. Preziosi, P. Galan, S. Bertrais, C. Estaquio, S. Briancon, A. Favier, J. Latreille, et al. Antioxidant Supplementation Increases the Risk of Skin Cancers in Women but Not in Men J. Nutr., September 1, 2007; 137(9): 2098 - 2105. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Marshall, W. Sakr, D. Wood, D. Berry, C. Tangen, F. Parker, I. Thompson, S. M. Lippman, R. Lieberman, D. Alberts, et al. Design and Progress of a Trial of Selenium to Prevent Prostate Cancer among Men with High-Grade Prostatic Intraepithelial Neoplasia. Cancer Epidemiol. Biomarkers Prev., August 1, 2006; 15(8): 1479 - 1484. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Connelly-Frost, C. Poole, J. A. Satia, L. L. Kupper, R. C. Millikan, and R. S. Sandler Selenium, apoptosis, and colorectal adenomas. Cancer Epidemiol. Biomarkers Prev., March 1, 2006; 15(3): 486 - 493. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Ray, R. D. Semba, J. Walston, L. Ferrucci, A. R. Cappola, M. O. Ricks, Q.-L. Xue, and L. P. Fried Low Serum Selenium and Total Carotenoids Predict Mortality among Older Women Living in the Community: The Women's Health and Aging Studies J. Nutr., January 1, 2006; 136(1): 172 - 176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Reid, A. J. Duffield-Lillico, L. Garland, B. W. Turnbull, L. C. Clark, and J. R. Marshall Selenium Supplementation and Lung Cancer Incidence: An Update of the Nutritional Prevention of Cancer Trial Cancer Epidemiol. Biomarkers Prev., November 1, 2002; 11(11): 1285 - 1291. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Duffield-Lillico, M. E. Reid, B. W. Turnbull, G. F. Combs Jr., E. H. Slate, L. A. Fischbach, J. R. Marshall, and L. C. Clark Baseline Characteristics and the Effect of Selenium Supplementation on Cancer Incidence in a Randomized Clinical Trial: A Summary Report of the Nutritional Prevention of Cancer Trial Cancer Epidemiol. Biomarkers Prev., July 1, 2002; 11(7): 630 - 639. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. D. Mark, Y.-L. Qiao, S. M. Dawsey, Y.-P. Wu, H. Katki, E. W. Gunter, J. F. Fraumeni Jr., W. J. Blot, Z.-W. Dong, and P. R. Taylor Prospective Study of Serum Selenium Levels and Incident Esophageal and Gastric Cancers J Natl Cancer Inst, November 1, 2000; 92(21): 1753 - 1763. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Y. Nomura, J. Lee, G. N. Stemmermann, and G. F. Combs Jr. Serum Selenium and Subsequent Risk of Prostate Cancer Cancer Epidemiol. Biomarkers Prev., September 1, 2000; 9(9): 883 - 887. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. C. Clark, G. F. Combs Jr, B. W. Turnbull, E. H. Slate, D. K. Chalker, J. Chow, L. S. Davis, R. A. Glover, G. F. Graham, E. G. Gross, et al. Effects of Selenium Supplementation for Cancer Prevention in Patients With Carcinoma of the Skin: A Randomized Controlled Trial JAMA, December 25, 1996; 276(24): 1957 - 1963. [Abstract] [PDF]
|
|
|
|
 |
|
 B. Henderson, R. Ross, and M. Pike Toward the primary prevention of cancer Science, November 22, 1991; 254(5035): 1131 - 1138. [Abstract] [PDF]
|
|
|
|
|
|
D. J. Hunter, J. S. Morris, M. J. Stampfer, G. A. Colditz, F. E. Speizer, and W. C. Willett A Prospective Study of Selenium Status and Breast Cancer Risk JAMA, September 5, 1990; 264(9): 1128 - 1131. [Abstract] [PDF]
|
|